about
ω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary RelevanceA wax ester and astaxanthin-rich extract from the marine copepod Calanus finmarchicus attenuates atherogenesis in female apolipoprotein E-deficient miceDietary enrichment of apolipoprotein E-deficient mice with extra virgin olive oil in combination with seal oil inhibits atherogenesis.Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids.The role of blood cells and their microparticles in blood coagulation.Dietary intake of cod and scallop reduces atherosclerotic burden in female apolipoprotein E-deficient mice fed a Western-type high fat diet for 13 weeks.Antioxidant and anti-inflammatory activities of barettin.Enzymatic Pre-Treatment Increases the Protein Bioaccessibility and Extractability in Dulse (Palmaria palmata).The potential of cod hydrolyzate to inhibit blood pressure in spontaneously hypertensive rats.Association of the -159 C --> T polymorphism in the CD14 promoter with variations in serum lipoproteins in healthy subjects.Antioxidant and Anti-Inflammatory Activities in Extracts from Minke Whale (Balaenoptera acutorostrata) Blubber.Characterization of protein, lipid and mineral contents in common Norwegian seaweeds and evaluation of their potential as food and feed.Proximate composition, antihypertensive and antioxidative properties of the semimembranosus muscle from pork and beef after cooking and in vitro digestion.Cold-pressed minke whale oil reduces circulating LDL/VLDL-cholesterol, lipid oxidation and atherogenesis in apolipoprotein E-deficient mice fed a Western-type diet for 13 weeks.Enhanced incorporation of n-3 fatty acids from fish compared with fish oilsEffects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects
P50
Q26782277-DD8E21FC-0A6B-4801-B17B-08E92F5FEF4FQ28259443-37205727-3512-461E-9509-F125EC8D6D64Q34668890-51EA9AD9-C435-433A-BFBB-7A0C9C698924Q34744473-9FC7D3E5-A270-4FF6-8509-321146B8824DQ36078644-83C4FD0E-FB12-4356-8186-356DBA488210Q36528993-80497CD5-3934-4838-947A-3A4E25571AD6Q39121099-A3D42D5C-9672-457C-A343-C7C98AB5BBE1Q42361508-9B070D9C-46A8-4AD7-9436-3319CFAA4379Q43536037-9DFBD5FD-4C3D-42D8-8933-EA562EE26F05Q44601235-844AB80E-329F-44BC-A1EE-E8818381F500Q44641613-65798A44-BA33-422D-85EF-4102F5857A2AQ46910023-AA6CECC7-27E7-4DF6-BACF-A53E1923C46EQ54629861-1BA922AF-AA1C-41C5-B724-7ABA4036AFF6Q55053427-3941CF22-6259-466C-AA96-6AA0DC8E601EQ79705372-F2E3DD1A-3107-4196-8371-81466A6439D3Q84943203-8425EA74-5B15-4FBE-AC85-5F09811C77FC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Karl-Erik Eilertsen
@ast
Karl-Erik Eilertsen
@en
Karl-Erik Eilertsen
@es
Karl-Erik Eilertsen
@nl
type
label
Karl-Erik Eilertsen
@ast
Karl-Erik Eilertsen
@en
Karl-Erik Eilertsen
@es
Karl-Erik Eilertsen
@nl
prefLabel
Karl-Erik Eilertsen
@ast
Karl-Erik Eilertsen
@en
Karl-Erik Eilertsen
@es
Karl-Erik Eilertsen
@nl
P106
P1153
6701744603
P31
P496
0000-0002-6033-7188